EDA Logo
Sorry, this website does not support this browser

Regulatory Guidelines

Guidance

Regulatory Guideline For General administration For Drug Utilization and Pharmacy practice

Type Issue Date Description Issue NO.
Guidance 2022 NATIONAL GUIDANCE FOR ANTIMICROBIAL PROPHYLAXIS IN SURGERY

01
Guidance 2022 NATIONAL GUIDANCE FOR SWITCHING ANTIBIOTICS FROM IV TO ORAL 01
Guidance 2022 Egyptian Guidance for Oncology Pharmacy Practice 01
Guidance 2022 National Guidance for Preauthorization of Restricted
Antimicrobials in hospitals National Antimicrobial Rational Use Committee

01
Guidance 2022 National Guidance of Antimicrobial Monitoring

01
Guidance 2023 Egyptian Guidance for Oncology Pharmacy PracticeVolume II
Chapter 1 -Biologics and Biosimilars		 01
Guidance 2023 National Guidance for Non-Surgical Antimicrobial
Prophylaxis

01
Guidance 2024 Egyptian Guidance for Oncology Pharmacy Practice
Volume II, Chapter II
Nuclear and Radiological Safety Principles and Practice
of Nuclear Pharmacy

01
Guidance 2024 National Guidance for Rational Antifungal Use

01
Guidance 2024

National Guidance for Antimicrobial Use in Infections with
Multi-Drug Resistant Organisms (MDROs)

  01
Guidance 2024 EDA Diabetes Guidance to Good Pharmacy Practice

01
Guidance 2024

Guidance Drug Therapy Problems and Medication Errors Reference Codes

01
Guidance 2024

Egyptian Guidance for Oncology Pharmacy Practice
Volume II
Chapter III
Role of Oncology Pharmacist in Radiotherapy

  01
Guidance 2024

National Guidance for the Rational Use of Duplicate Antimicrobial Therapy

  01
Guidance 2025 National Guidance of Rational Antimicrobial Use in the Management of Skin and Soft Tissue Infection 01
Guidance 2025 EDA Renal Anaemia Guidance to Good Pharmacy Practice 01
Guidance 2025

Egyptian Guidance for Oncology Pharmacy Practice
Pharmacist’s Role in Personalized Medication Management

part 1

 01

 

 

Copy Rights @ EDA 2021